Inventor · disambiguated record
Urs Baettig
Also filed as: BAETTIG URS
20 granted patents·4 pending applications·180 citations·filing 2004–2021
94Inventor score
Top patents by PatentIndex Score
24 records- 0196US8247436B2Pyridine and pyrazine derivative for the treatment of CFBAETTIG URS·Filed 2011·Granted Aug 21, 2012·87 cites·9 claims
- 0290US8722925B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2012·Granted May 13, 2014·13 cites·7 claims
- 0390US7989497B2Squaramide derivatives as CXCR2 antagonistNOVARTIS AG·Filed 2009·Granted Aug 2, 2011·13 cites·16 claims
- 0489US9115087B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2014·Granted Aug 25, 2015·11 cites·13 claims
- 0589US8288588B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2011·Granted Oct 16, 2012·11 cites·15 claims
- 0688US8329754B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2011·Granted Dec 11, 2012·11 cites·9 claims
- 0786US8476269B2Pyridine and pyrazine derivative for the treatment of CFBAETTIG URS·Filed 2012·Granted Jul 2, 2013·7 cites·12 claims
- 0884US9365552B2Pyridine and pyrazine derivative for the treatment of CFNOVARTIS AG·Filed 2014·Granted Jun 14, 2016·5 cites·17 claims
- 0981US10117858B2Pyridine and pyrazine derivative for the treatment of CFNOVARTIS AG·Filed 2016·Granted Nov 6, 2018·2 cites·17 claims
- 1080US8343966B2Organic compoundsNOVARTIS AG·Filed 2009·Granted Jan 1, 2013·6 cites·2 claims
- 1178US7723356B2Quinuclidine derivatives and their use as muscarinic m3 receptor antagonistsNOVARTIS AG·Filed 2005·Granted May 25, 2010·3 cites·8 claims
- 1276US11911371B2Pyridine and pyrazine derivative for the treatment of chronic bronchitisNOVARTIS AG·Filed 2021·Granted Feb 27, 2024·0 cites·22 claims
- 1374US7947730B2Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptorNOVARTIS AG·Filed 2004·Granted May 24, 2011·7 cites·9 claims
- 1473USRE46757EPyridine and pyrazine derivative for the treatment of CFNOVARTIS AG·Filed 2015·Granted Mar 20, 2018·1 cites·21 claims
- 1570US8168654B2Quinuclidine derivatives binding to mucarinic M3 receptorsCOLLINGWOOD STEPHEN P·Filed 2009·Granted May 1, 2012·2 cites·16 claims
- 1668US9763957B2Autotaxin inhibitorsNOVARTIS AG·Filed 2014·Granted Sep 19, 2017·1 cites·7 claims
- 1766US2019262324A1Pyridine and Pyrazine Derivative for the Treatment of CFNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1862US2014135329A1Pyridine and Pyrazine derivative for the Treatment of CFBAETTIG URS·Filed 2013·Application pending·0 cites
- 1946US10183025B2Autotaxin inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 22, 2019·0 cites·5 claims
- 2044US2016168119A1Autotaxin inhibitorsBAETTIG URS·Filed 2014·Application pending·0 cites
- 2141US2008312322A1Organic CompoundsBAETTIG URS·Filed 2006·Application pending·0 cites
- 2240US9018261B2Choline salt of an anti-inflammatory substituted cyclobutenedione compoundAMBARKHANE AMEET VIJAY·Filed 2012·Granted Apr 28, 2015·0 cites·20 claims
- 2340US8084463B2Quinuclidine derivatives and their use as muscarinic M3 receptor antagonistsPRESS NEIL J·Filed 2010·Granted Dec 27, 2011·0 cites·7 claims
- 2440US7678826B2Organic compounds for the treatment of inflammatory or allergic conditionsAXFORD JAKE·Filed 2006·Granted Mar 16, 2010·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Urs Baettig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →